Vanguard Fiduciary Trust’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.16M Buy
887,677
+8,844
+1% +$58.6K ﹤0.01% 2155
2026
Q1
$6.37M Buy
+878,833
New +$11.4M ﹤0.01% 1950

Other funds holding WVE

Vanguard Fiduciary Trust's WVE Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Wave Life Sciences (WVE) stake by 1% in Q2 2026, buying an estimated $58.6K and bringing the position to 887,677 shares worth $5.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2155.

Vanguard Fiduciary Trust first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.37M in Q1 2026. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Vanguard Fiduciary Trust held 887,677 shares of Wave Life Sciences worth $5.16M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 8,844 Wave Life Sciences shares in Q2 2026, an estimated $58.6K.
  • Wave Life Sciences made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2155 holding.
  • Vanguard Fiduciary Trust first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Wave Life Sciences position peaked at $6.37M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.